Director Carol Burt filed a Form 4 with the SEC on November 20, 2026, disclosing the acquisition of 1,109 Restricted Stock Units of ResMed Inc on November 19, 2026, at a price of $0.
Key Highlights
- RSU Award: Carol Burt, a director of ResMed Inc, acquired 1,109 Restricted Stock Units on November 19, 2026, at a price of $0.
- Vesting Schedule: The RSUs vest in full on the earlier of November 11, 2027, or the annual meeting of stockholders in the year following the grant date.
- Direct Holdings: Following the transaction, Burt directly holds 3,265 shares of ResMed Common Stock.
- Indirect Holdings: Burt also holds 16,660 shares indirectly through the Carol Burt Hilliard Trust.
- Transaction Code: The acquisition is recorded under transaction code A (Award), indicating a grant rather than an open-market purchase.
ResMed Director Carol Burt Receives RSU Grant, Lifting Total Holdings to 19,925 Shares
According to a Form 4 filed with the U.S. Securities and Exchange Commission on November 20, 2026, ResMed Inc (NYSE:RMD) director Carol Burt was awarded 1,109 Restricted Stock Units on November 19, 2026. The filing records the acquisition under transaction code A, with a stated price of $0, consistent with an equity award rather than a market purchase.
The filing discloses that the RSUs will vest in full on the earlier of November 11, 2027, or the date of the annual meeting of stockholders in the year following the grant date. Following the reported transaction, Burt directly holds 3,265 shares of ResMed Common Stock. In addition, the filing reports 16,660 shares held indirectly through the Carol Burt Hilliard Trust, bringing the total reported beneficial ownership to 19,925 shares across both direct and indirect holdings.
The Form 4 was signed by Carol Burt in her capacity as director and was filed on November 20, 2026, the day after the transaction date. No derivative securities transactions were reported in Table II of the filing.
What Was Disclosed
ResMed director Carol Burt disclosed the receipt of 1,109 RSUs on November 19, 2026, at no cost, vesting no later than November 11, 2027. After the award, her total reported beneficial ownership stands at 3,265 shares directly and 16,660 shares indirectly via trust.



Please wait processing your request...